Item 8. Financial Statements and Supplementary Data
Item 8. Financial Statements and Supplementary Data
The financial statements of the Company are contained on pages F-1 through F-27 of this Annual Report and are incorporated herein by reference.
Selected quarterly financial data is presented below for each quarter in fiscal year 2023 to reflect the Company's material retrospective change due to its conversion from IFRS to U.S. GAAP.
For the three months ended
March 31,
2023
June 30,
2023
September 30, 2023
December 31, 2023
(In thousands of USD, except per share amounts)
Revenue
8,629
1,717
2,941
803
Operating expenses:
Research and development expenses
40,420
34,341
43,371
41,292
Selling, general and administrative expenses
8,062
9,858
9,128
10,585
Total operating expenses
48,482
44,199
52,499
51,877
Operating loss
(39,853
)
(42,482
)
(49,558
)
(51,074
)
Loss for the period
(42,018
)
(38,292
)
(47,132
)
(49,495
)
Net loss per ordinary share
Basic and diluted
$
(0.51
)
$
(0.47
)
$
(0.57
)
$
(0.60
)
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.